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The adult brain functions within a well-controlled stable environment, the properties of
which are determined by cellular exchange mechanisms superimposed on the diffusion
restraint provided by tight junctions at interfaces between blood, brain and cerebrospinal
ﬂuid (CSF).These interfaces are referred to as “the” blood–brain barrier. It is widely believed
that in embryos and newborns, this barrier is immature or “leaky,” rendering the develop-
ing brain more vulnerable to drugs or toxins entering the fetal circulation from the mother.
New evidence shows that many adult mechanisms, including functionally effective tight
junctions are present in embryonic brain and some transporters are more active during
development than in the adult. Additionally, some mechanisms present in embryos are not
present in adults, e.g., speciﬁc transport of plasma proteins across the blood–CSF barrier
and embryo-speciﬁc intercellular junctions between neuroependymal cells lining the ven-
tricles. However developing cerebral vessels appear to be more fragile than in the adult.
Together these properties may render developing brains more vulnerable to drugs, toxins,
and pathological conditions, contributing to cerebral damage and later neurological disor-
ders. In addition, after birth loss of protection by efﬂux transporters in placenta may also
render the neonatal brain more vulnerable than in the fetus.
Keywords: blood–brain barrier, blood–CSF barrier, epithelial cell transport, endothelial cell transport, cerebrospinal
fluid, fetus, newborn
INTRODUCTION
Understanding the role of blood–brainbarriermechanisms innor-
mal brain development and possible deleterious effects should
these mechanisms be dysfunctional is important from the clin-
ical perspective of whether or not drugs or toxins, once they
cross the placenta, may have access to the vulnerable developing
brain. A reason given by regulatory bodies in US and European
Union for caution in giving drugs to pregnant women or infants
is “immaturity” of the blood–brain barrier1,2.
One historical reason for belief in barrier immaturity comes
from teleological thinking that fetal brains would not need a bar-
rier, because the fetus is protected by a placenta (Barcroft, 1938).
The developing brain is necessarily immature compared to that
of the adult, but the real question should be about the functional
status of the blood–brain barrier mechanisms in embryos, fetuses,
and infants, compared to adults.
There is a widespread belief amongst pediatricians, neurol-
ogists, neuroscientists, and neurotoxicologists that “the” blood–
brain barrier in the embryo, fetus, and newborn is “immature”
implying that it is poorly formed, leaky, or even absent. State-
ments about the immaturity of the blood–brain barrier frequently
seem to be made without evidence, or by reference to an earlier
review that also lacks any evidence (e.g., Järup, 2003; Costa et al.,
2004; Watson et al., 2006). This seems to be particularly common
in the neurotoxicology literature and in toxicology reports (see
review by Ek et al., 2012).
Abbreviations: BCRP, breast cancer resistance protein; CSF, cerebrospinal ﬂuid.
1http://www.atsdr.cdc.gov/csem/pediatric/docs/pediatric.pdf
2www.emea.europa.eu
FUNCTIONAL SIGNIFICANCE OF EARLY DEVELOPMENT OF
BRAIN BARRIERS
Without the diffusion restraint provided by intercellular junctions
in brain barrier interfaces it would not be possible to establish
efﬂux or inﬂux mechanisms such as those controlling ionic gradi-
ents between blood and cerebrospinal ﬂuid (CSF; Bito and Myers,
1970; Bradbury et al., 1972; Amtorp and Sørensen, 1974; and
see Saunders, 1992 for review). In effect, these junctions con-
vert the transport properties of individual cerebral endothelial
and choroid plexus epithelial cells into those of the whole inter-
faces separating blood from brain. Thus transfer from blood to
brain and CSF occurs across these interfaces and is known to be
present from early stages of brain development for a wide range
of metabolically important molecules: glucose (Dermietzel et al.,
1992; Vannucci, 1994; Vannucci et al., 1994; Bauer et al., 1995),
amino acids (Braun et al., 1980; Cornford et al., 1982; Pardridge
and Mietus, 1982; Lefauconnier and Trouvé, 1983), and hormones
(Hagenbuch, 2007). The molecular structure of tight junctions
of the blood–brain barrier proper in the adult brain has been
extensively studied and reviewed (e.g., Abbott et al., 2010).
Figure 1 illustrates the brainof anE16 rat brain immunostained
with antibodies to total plasma protein. There is no evidence for
any proteins escaping the vasculature, demonstrating functional
effectiveness of the blood–brain barrier even so early in develop-
ment. At this stage of rat development in the brain there are very
few blood vessels and the cortex only becomes well vascularized
after birth. In contrast, choroid plexuses are already a signiﬁcant
size (Figure 1C) and grow rapidly during the remainder of ges-
tation. It appears that in early stages of brain development the
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FIGURE 1 | Embryonic day E16 rat brain stained for endogenous plasma
proteins. (A) Low power coronal section. Immunostaining in CSF, choroid
plexus, and ventricular zone, also few blood vessels in cortex. (B) Higher
power of cortex: immunostaining in mesenchymal tissue outside brain
surface and blood vessels (arrows), not in brain parenchyma. (C) Choroid
plexus: immunostaining in some epithelial cells (arrowheads) and stroma. (D)
Immunostaining in neuroependymal cells and blood vessels, not in brain
parenchyma outside neuroependyma. Open arrows: sites of strap junctions.
Images reproduced from Saunders and Habgood (2011). Scale bars: (A),
100μm; (B,D), 25μm; (C), 50μm.
choroid plexuses are the main portals of molecular transfer from
blood into brain (Johansson et al., 2008; Liddelow et al., 2009).
Thus far from being incomplete or “leaky,” barriers in devel-
oping brain are adapted to fetal environments. However, it is
important to distinguish functional effectiveness of early tight
junctions at the blood–brain barrier from the evidence for their
continued molecular and structural organization. This may relate
to increased hydrostatic pressure that occurs during fetal devel-
opment as systemic blood pressure rises in parallel with plasma
protein concentration that provides the“colloid”osmotic pressure
important for ﬂuid exchange across capillaries.
EARLY STUDIES OF THE BLOOD–BRAIN BARRIER IN THE
DEVELOPING BRAIN
DYE EXPERIMENTS
Ehrlich (1885) and Goldmann (1909) showed that parenteral
injections of trypan blue and other acidic dyes resulted in stain-
ing of almost all tissues except the brain. Biedl and Kraus (1898)
and Lewandowsky (1900) found that even the much smaller mol-
ecules: bile and sodium ferrocyanide (demonstrated with Prussian
blue reaction) only had toxic effects when injected directly into the
brain. It was these early experiments that led to the concept of the
brain being protected by a mechanism called the blood–brain bar-
rier, a term that appears to have been ﬁrst used by Lewandowsky
(1900). These experiments were soon followed by similar ones
using embryos or newborns of various species. Most of the early
reports of experiments using trypan blue gave the same result
as in adults, i.e., most of the brain was not stained apart from
the circumventricular organs (Wislocki, 1920, guinea pig embryo;
Stern and Peyrot, 1927; Stern and Rapoport, 1928; Stern et al.,
1929, newborn rats, rabbits, and guinea pigs). Stern et al. (1929)
stressed the importance of not injecting too much dye. This may
explain one of the few early reports of brain staining following
dye injection by Penta (1932) because he used multiple and such
large injections that most of his experimental animals (newborn
rabbits) died from the toxic effects of the dye (see Saunders, 1992).
Behnsen (1927) is perhaps the most frequently cited paper sup-
posedly showing staining of the brain following dye injections in
postnatal mice. However, his paper did not actually show this but
instead his results illustrated that the sites of dye entry in the adult
animals corresponded precisely to sites of maximal accumulation
in the young mice. Rather curiously Behnsen (1927) chose to illus-
trate his ﬁndings with drawings of sagittal sections using adult
mouse brain for both adult and postnatal (2–3week old) animals.
Since areas of the brain such as the cerebral cortex are not yet fully
developed at 2–3weeks of age, the distribution of dye at this age
would have appeared more widespread than in the adult, without
actually being so. In the brain region with the least mature blood
vessels (cerebral cortex) there was no dye staining of the brains of
the younger mice. A key often overlooked reference in the ﬁeld is
the one in which both rabbit and human fetal material was studied
using trypan blue injections (Gröntoft, 1954). The study showed
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clearly that in human fetuses (5–26 cm long) obtained from legal
abortions, providing the dye was injected within 10min following
placental separation, the brains remained dye-free indicating that
the blood–brain barrier was impermeable to the dye; at later times
or in aborted embryos that could not be examined until some
time after delivery, the brains stained blue following dye injection.
Gröntoft (1954) considered this to be due to an effect of asphyxia
on the blood–brain barrier following the death of the fetuses. He
conﬁrmed this under controlled experimental conditions in rabbit
fetuses in which he was able to study the brains at predetermined
times after injection and death of the fetuses.
SODIUM FERROCYANIDE
Sodium ferrocyanide is a small molecular weight compound (mol
wt 204) about the same size as sucrose (342Da; molecular radius
5.1 Å). When treated with acid it gives a blue color (Prussian blue
reaction). In what was probably the ﬁrst brain barrier experiment
in an embryo, Weed (1917) injected sodium ferrocyanide into the
neural tube of pig embryos (19mm, E20; term is 114 days) and
showed that the blue staining following treatment with slightly
acidic solutions of iron salts (Prussian blue reaction) was con-
ﬁned to the neural tube and did not penetrate out into rest of the
embryo. This paper seems to have been overlooked by the blood–
brain barrier ﬁeld, perhaps because it is the converse of a classical
barrier experiment in which the marker was injected parenterally
(cf. Stern and Peyrot, 1927; Stern and Rapoport, 1928; Stern et al.,
1929).
In spite of the above studies clearly showing lack of penetration
of small molecular compounds even into an embryonic brain,
there are nevertheless numerous reports claiming an absence or
immaturity of the blood–brain barrier in the fetus and neonate
continue to be published (see Ek et al., 2012 for review).
There are severalwell-known fetal-speciﬁcmechanisms that are
different from the adult that reﬂect adaptation to a fetal-speciﬁc
environment (e.g., fetal hemoglobin, Palis et al., 2010). Similarly,
during development, brain barriers demonstrate some important
differences, particularly in transport mechanisms, many of which
have only recently begun to be described. These differences prob-
ably reﬂect mechanisms important for brain development rather
than deﬁciencies compared to adult brain. This review will sum-
marize the main brain barrier mechanisms in the adult and during
development. In the last part of the review we shall consider evi-
dence that blood–brain barrier mechanisms, while functionally
effective in the developing brain,may nonetheless be more suscep-
tible than in the adult to adverse circumstances and that damage
to brain barrier mechanisms during development may lead to
neurological and neuropsychological dysfunction in later life.
BRAIN BARRIERS
The main interfaces across which exchange occurs between the
blood and the internal environment of the brain (brain intersti-
tial ﬂuid and CSF) are illustrated in Figure 2. There are ﬁve main
barrier interfaces involved: (i) the blood–brain barrier proper at
the level of the endothelium of the cerebral blood vessels; (ii) the
arachnoid barrier between the CSF in the subarachnoid space and
the dura; (iii) the pia/glia limitans between the CSF and extracellu-
lar ﬂuid of the brain, which is much more complex in the embryo;
(iv) the CSF–brain barrier, which is only a signiﬁcant barrier in
the embryo, created by separation of the ventricular system from
the extracellular ﬂuid of the brain by strap junctions in the neu-
roependyma; and (v) the blood–CSF barrier at the level of the
choroid plexus epithelial cells (Figure 2).
CELLULAR CONSTITUENTS OF BARRIER INTERFACES IN THE
DEVELOPING BRAIN
The principal morphological basis of these barriers lies in inter-
cellular junctions that provide a diffusional restraint between
compartments.
The neurovascular unit
The term blood–brain barrier has a long history, but it has become
increasingly recognized that it does not adequately encompass the
wide range of morphological features and functional character-
istics that it is now known to involve. For this reason the term
“neurovascular unit” (Neuwelt, 2004) is being increasingly used.
It comprises the endothelial cells, pericytes, microglia, astrocytes,
andbasementmembrane that are characteristic of the cerebral vas-
culature. The term refers more to the close anatomical and func-
tional association of these different cell types without implying
any speciﬁc mechanisms.
Endothelial cells
Two features characterize the cerebral endothelial cells that con-
stitute the blood–brain barrier. These are circumferential tight
junctions, which occlude the intercellular space between adjacent
endothelial cells and a lack of pinocytotic vesicles in the cyto-
plasm (Brightman and Reese, 1969). There are several reports that
there are many more vesicles in the endothelial cells of developing
brain vasculature (Donahue andPappas,1961;Dziegielewska et al.,
1979) with a decline as development proceeds. In contrast Stewart
and Hayakawa (1987, 1994) reported that vesicles were virtually
absent in early cerebral blood vessels. This discrepancy could per-
haps be due to differences in ﬁxation or to different classes of blood
vessels being examined. Dziegielewska et al. (1979) also reported
that following intravenous Alcian blue injection in fetal sheep, the
dye (which is electron-dense and binds to plasma albumin) could
be seen within numerous vesicles and tubules in the cytoplasm of
the endothelial cells; dye was also present in the basement mem-
brane, but not inside tight junctions. However, this aspect of brain
barrier development has otherwise been little studied. In contrast
the question of whether cerebral interendothelial tight junctions
in early brain development are as impermeable to markers such
as dyes or horseradish peroxidase has attracted a lot of attention,
with conﬂicting results being reported overmany years. Thus some
early studies using transmission electronmicroscopy and/or freeze
fracture, showed well-formed tight junctions between cerebral
endothelial cells from early in vascularization of the brain (Møll-
gård and Saunders, 1975; Møllgård et al., 1979; Bass et al., 1992;
Bauer et al., 1993). Some studies claimed that cerebral endothelial
tight junctions in fetal mouse and rat brain showed ultrastruc-
tural features such as the proportion of the junction composed
of zonulae occludens which increased, while junctional clefts
decreased, and expanded junctional clefts virtually disappeared
(Stewart and Hayakawa, 1987, 1994). In a freeze fracture study,
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FIGURE 2 | Brain barrier interfaces. (A) Blood–cerebrospinal ﬂuid (CSF)
barrier: tight junctions between choroid plexus epithelial cells. (B)
Blood–brain barrier: tight junctions between endothelial cells. (C) CSF–brain
barrier only present in embryos and fetuses: strap junctions between
neuroependymal cells. (D) CSF–brain interface in adult: gap junctions
between ependymal cells, with free diffusion pathway (Arrowheads and
broken lines). (E) Arachnoid barrier. In adult: tight junctions between cells of
the inner layer of the arachnoid membrane and between endothelial cells of
pial blood vessels. In embryos: additional membrane specializations at the
CSF–pial interface (Møllgård et al., 1987). Abbreviations: bv, blood vessel;
endo, endothelial cell; epi, epithelial cell; bm, basement membrane; peri,
pericyte; astro, astrocyte (astrocytes not yet differentiated in brain when
blood vessels ﬁrst appear; thus they cannot contribute to tight junction
formation in early brain development). Black arrowheads: sites of tight
junctions; open arrowheads: sites of strap junctions. Redrawn from
Saunders et al. (2008).
Kniesel et al. (1996) identiﬁed changes in strand pattern during
cerebral vascular development, which they suggested correlated
with greater permeability and subsequent developmental decline
in blood–brain barrier permeability. Stewart andHayakawa (1987)
assessed blood–brain barrier permeability by measuring perox-
idase activity in homogenized brain at different ages. However,
the choroid plexuses are disproportionately larger in the develop-
ing brain (Johansson et al., 2008) and transfer proteins across their
epithelial cells (see below). It is unclearwhether choroid plexuswas
removed from the brain samples and the possibility that HRP may
have entered the brain via the plexuses was not considered. Kniesel
et al. (1996) did not include any permeability studies in parallel
with their ultrastructural observations, but relied on comparisons
with in vitro cultures of cerebral endothelial cells to support their
conclusion that changes in freeze fracture replicas with age corre-
lated with supposed greater blood–brain barrier permeability in
the developing brain.
Later studies (Nitta et al., 2003; Ek et al., 2006) appear to con-
ﬁrm the earlier ﬁndings of well-formed tight junctions in the
early stages of vascularization of the brain. The advent of small
molecular sized water-soluble probes that can be visualized at the
electron microscopical level has shown that these junctions are
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indeed functionally tight to small molecules (Ek et al., 2006). Thus
in these more recent light microscopical and ultrastructural stud-
ies using amounts of tracer that only increased circulating blood
volume and protein concentration to a limited extent (<10%) the
tight junctions of endothelial cells in cerebral blood vessels and
in embryos and neonates were found to restrict the passage of
low molecular weight molecules (Ek et al., 2006; Johansson et al.,
2006; Daneman et al., 2010a). In contrast, some earlier studies
in the developing brain claimed leakiness of cerebral blood ves-
sels, but used large injection volumes or concentrations of the
tracer horseradish peroxidase (e.g.,Wakai and Hirokawa, 1978a,b;
Risau et al., 1986; Risau andWolburg, 1990; see Saunders, 1992 for
review). The more recent ﬁndings of Ek et al. (2006), Johansson
et al. (2006), and Daneman et al. (2010a) show that the physi-
cal basis for the brain barrier mechanism is already present and
functionally effective from very early in development.
Immunolocalization of tight junctional proteins, such as
claudin 5 and occludin, shows that these are present in brain
barrier interfaces soon after blood vessels invade the brain inmam-
mals (Ek et al., 2006; Daneman et al., 2010a) including humans
(Virgintino et al., 2004). Many of the molecular studies of tight
junction proteins have been carried out using in vitro prepara-
tions, often of cultures of artiﬁcial cell lines such as Madin–Darby
bovine kidney (MDBK) cells and human intestinal epithelial cells
(T84; Furuse et al., 1994, 2001; Itoh et al., 2001) mouse embryonic
feeder cells (Saitou et al., 1998) MDCK cells (Sonoda et al., 1999;
Colegio et al., 2003; Blasig et al., 2006). These studies have provided
valuable insights into the molecular structure of tight junctions,
which could then be followed up in material from normal brain
endothelia and epithelia in vitro (Hirase et al., 1997; Haseloff et al.,
2005; Cohen-Kashi Malina et al., 2009) and in vivo (Nitta et al.,
2003; Furuse and Tsukita, 2006; Sadowska et al., 2009; Xie et al.,
2010). However,when used to assess barrier interface permeability
in vitro this has usually been done indirectly bymeasuring transep-
ithelial or transendothelial resistance (TEER), which is assumed
to equate to a low resistance pathway via tight junctions (Frömter
and Diamond, 1972). It is not clear how well these in vitro sys-
tems reﬂect the situation in vivo, but it is becoming increasingly
clear that they may not always do so, resulting in a number of
misleading conclusions. As pointed out by Armulik et al. (2011),
it was considered for some years on the basis of in vitro studies
that pericytes played an important role in development and main-
tenance of cerebral interendothelial cell tight junctions; however
two studies of transgenicmice with deﬁcient pericytes showed that
in these animals an increase in vascular permeability correlated
with increased endothelial transcytosis rather than tight junction
permeability (Armulik et al., 2010; Daneman et al., 2010b) as is
discussed in the next section.
Pericytes
Daneman et al. (2010b) compared mice with null and hypomor-
phic alleles of Pdgfrb (platelet-derived growth factor receptor-β)
which have defects in pericyte generation. They showed that
pericytes are necessary for formation of a functionally effective
blood–brain barrier and that pericyte coverage of blood vessels
determines relative vascular permeability. Pericytes were found
to regulate functional formation of tight junctions and vesicle
trafﬁcking in CNS endothelial cells, however, they did not induce
blood–brain barrier speciﬁc gene expression in cerebral endothe-
lial cells; rather they inhibited the expression of molecules that
increase vascular permeability and inﬁltration of immune cells.
These effects on blood–brain barrier formation occurred a week
before the differentiation of astrocytes, the cells that many have
suggested are responsible for induction of tight junctions during
blood–brain barrier formation (see next section).
Astrocytes
In the adult brain astrocytic end feet encircle almost the entire cir-
cumference of endothelial cells of cerebral capillaries (Caley and
Maxwell, 1970; Xu and Ling, 1994). They are an important compo-
nent of the neurovascular unit and are thought to make signiﬁcant
contributions to blood–brain barrier functions (Abbott et al.,
2006). Their role in the developing brain has been more contro-
versial. When in vitro blood–brain barrier models were ﬁrst being
developed it was found that the presence of either cultured astro-
cytes or conditioned medium from cultured astrocytes produced
cells with more complex tight junctions (Tao-Cheng et al., 1987)
and this was essential for the preparation of cerebral endothe-
lial monolayers with high transendothelial resistance (Dehouck
et al., 1990; Rubin et al., 1991). A study that has been particu-
larly inﬂuential in discussion of the possible role of astrocytes in
development of blood–brain barrier properties in the immature
brain was that of Janzer and Raff (1987). These authors cultured
cerebral endothelial cells in the anterior chamber of the eye and
reported that only in the presence of astrocytes were blood ves-
sels formed that retained dye within their lumena. They compared
astrocyte implants with ﬁbroblast implants and found that the ves-
sels associated with the ﬁbroblast grafts were“leaky” to Evans blue.
Janzer and Raff (1987) interpreted their results as evidence that
blood vessels with impermeable tight junctions were formed in the
presence of astrocytes. However, this was not conﬁrmed by elec-
tron microscopy; without ultrastructural evidence a claim of tight
junction formation was unwarranted. The study was repeated by
Holash et al. (1993) who did include electronmicroscopical obser-
vations. They found that astrocytes implanted into the anterior
chamber formed grafts that were poorly vascularized and when
examined by electron microscopy the iridial blood vessels associ-
ated with the astrocyte grafts did not change their ultrastructural
characteristics to those of brain capillaries. In addition, grafted
ﬁbroblasts formed invasivemasses that werewell vascularizedwith
fenestrated (non-barrier) blood vessels. Holash et al. (1993) sug-
gested that it was the contrast in dye penetration into these well
vascularized ﬁbroblast grafts compared to the poorly vascularized
astrocyte grafts that led to the incorrect conclusion of barrier for-
mation in vessels penetrating the astrocyte grafts. However, this
study is rarely cited in contrast to the paper of Janzer and Raff
(1987), a depressing reﬂection that even scientists will cite the evi-
dence that supports their preconceived ideas, not to mention the
undue inﬂuence of some journals in which a particular study is
published. A limitation of studies of blood–brain barrier inter-
faces in vitro is that the endothelial cells used were generally from
adult brains and would therefore already have their adult proper-
ties; however it may be that their role is in maintenance of tight
junctions rather than in their initial formation.
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What seems to have been overlooked by the proponents of the
idea that astrocytes are essential for tight junction formation in the
blood vessels of the developing brain is that there are no astrocytes
present in the developing brain when it is ﬁrst vascularized (Caley
and Maxwell, 1970; Daneman et al., 2010a). As ﬁrst shown by
Stewart and Wiley (1981) using chick-quail chimeras, tight junc-
tion formation in cerebral vessels is induced by some factor in the
neural tissue of the developing brain. The vessels are tight to pro-
teins and smallmolecules from as early as vessels ﬁrst grow into the
neural tissue (Bauer et al., 1993; Ek et al., 2006). It is not yet clear
what the induction factor(s) is/are. However, as indicated above it
seems that the pericytes make an important contribution to tight
junction formation (Daneman et al., 2010b). The main period
of differentiation of astrocytes and the encirclement of capillaries
occur in rodents in the ﬁrst 3 weeks of postnatal life; this is also the
main period of vascularization of the developing brain in rodents
(Caley and Maxwell, 1970). Thus it is possible that astrocytes con-
tribute to tight junction–induction during this period of intense
vascularization.
Basement membrane
The basement membrane surrounds all cerebral capillaries and is
an important component of the neurovascular unit. Bär andWolff
(1972) have given a detailed ultrastructural description of forma-
tion of the basement membrane around capillaries from E14 in rat
cerebral cortex. The basement membrane is thought to be formed
by secretion of constituents by cerebral endothelial cells and by
pericytes (Stratman and Davis, 2011) embedded in this structure
(Figure 1B). There is also evidence that astrocytes contribute at
later stages in vascularization of the brain (del Zoppo and Milner,
2006). The main constituents of the basement membrane are type
IV collagen from endothelial cells and type I collagen from peri-
cytes aswell as ﬁbronectin, thrombospondin (Canﬁeld et al., 1989),
and agrin (Barber and Lieth, 1997). In the developing brain base-
ment membrane is apparent at least as early as E20 in rat fetuses
and becomes denser and wider in the postnatal brain (Donahue
and Pappas, 1961). In human fetuses it has been identiﬁed in cere-
bral capillaries at least as early as 8 weeks gestation in a detailed
immunohistochemical study of the distribution of laminin β1 and
laminin β2 chains (Roediger et al., 2010).
Wnt/βCATENIN PATHWAY IN BLOOD–BRAIN BARRIER DEVELOPMENT
A major contribution to understanding the early stages of blood–
brainbarriermechanismdevelopmentwas thepublicationof three
papers implicating the Wnt/βcatenin pathway in some important
features of blood–brain barrier function (Liebner et al., 2008; Sten-
man et al., 2008; Daneman et al., 2009). Wnt is an acronym for
wingless (wg) ﬁrst identiﬁed in Drosophila and INT-1, ﬁrst iden-
tiﬁed in virally induced mammary tumors in mice. They are the
two founding member genes of the Wnt signaling pathway. Thus
far three major pathways downstream from Wnt have been iden-
tiﬁed. Of these the Wnt/β-catenin pathway seems to be important
for aspects of angiogenesis and blood–brain barrier development.
The Wnt/βcatenin pathway is also referred to as the canonical
Wnt signaling pathway (canonical: “Of the nature of a general rule
or standard formula” Oxford English Dictionary). Signaling via
Wnt involves a complex molecular mechanism the end result of
which is blockingof intracellularmechanisms thatwouldnormally
result in ubiquitination and proteasome-dependent degradation
(Rudloff et al., 2011). Several studies have shown that interfer-
ence with the Wnt/β-catenin pathway results in reduced vessel
numbers, loss of capillary beds, and formation of hemorrhagic
vascular malformations; in addition Wnt/β-catenin signaling has
also been shown to regulate the expression of the blood–brain
barrier-speciﬁc glucose transporter glut-1 (Stenman et al., 2008;
Daneman et al., 2009). In a study using different transgenic mice
at postnatal ages and primary cultures of mouse brain endothe-
lial cells (the age of the animals from which these were derived
was not speciﬁed) Liebner et al. (2008) reported that Wnt/β-
catenin signaling was important for the regulation of two key
tight junction proteins, claudin 3 and claudin 5. In contrast,
Daneman et al. (2009) reported no effect of down regulation of
the Wnt/β-catenin pathway on regulation of the tight junction
proteins, occludin and claudin 5 in E11.5 endothelial-speciﬁc β-
catenin mutants. It is not clear whether this difference was due
to the mutants used or the age at which they were examined. The
Wnt/β-catenin pathwaywas found to be active inmany endothelial
cells of developing brain from as early as E9.5; expression declined
after E15.5 to a lower level that was maintained in the neona-
tal period, but by adulthood expression was rare (Liebner et al.,
2008).
There is general agreement that Wnt ligands are present in
early neural progenitors of the ventricular zonewith some regional
speciﬁcity (Stenman et al., 2008; Daneman et al., 2009). Thus vas-
cular Wnt activation temporally correlates with the expression of
Wnt7a and Wnt7b in the developing forebrain and in the ventral
and intermediate spinal cord;Wnt4 in the dorsal and intermediate
spinal cord; and Wnt1, Wnt3, and Wnt3a throughout the dorsal
neural tube (Daneman et al., 2009).
MENINGEAL BARRIER
At the blood–brain interface over the outer surface of the brain
within the pia-arachnoid, the blood vessels also have tight junc-
tions between the endothelial cells, but their cellular transport
properties have been little studied. Other important interfaces are
between the CSF and brain interstitium at the inner (ventricu-
lar) and outer (subarachnoid) spaces. In the adult, cells lining
these interfaces are linked by gap junctions, which do not signif-
icantly hinder intercellular passage of molecules. However, in the
early stages of brain development the cells lining these interfaces
are more heterogeneous and are linked by strap junctions, which
occlude the intercellular space except to the smallest molecules;
this additional barrier provides a speciﬁc internal milieu for the
developing brain, in contrast to free exchange between CSF and
brain present in the adult (Fossan et al., 1985; Saunders, 1992;
Balslev et al., 1997a).
CHOROID PLEXUSES
The molecular make-up of tight junctions of the blood–CSF bar-
rier is less well-known (Wolburg et al., 2001). A recent study of
tight junction protein expression in mouse embryos (E15) and
adult choroid plexus (Liddelow et al., 2012) has shown that sev-
eral key junctional genes are expressed at a higher level in embryos
than in the adults, whereas for several other genes the reverse is the
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case (Table 1). This is consistent with previous ﬁndings that the
fundamental functional basis of this barrier, namely occlusion of
the paracellular diffusion pathway, is well established from the ear-
liest stages of differentiation of the choroid plexuses (Bauer et al.,
1993; Ek et al., 2003, 2006).
APPARENT INCREASED PERMEABILITY OF BARRIERS IN
DEVELOPING BRAIN
SMALL LIPID INSOLUBLE MOLECULES
Studies have been carried out in fetuses and newborn of many
species using classical radiolabeled physiological permeability
markers, sucrose and inulin. These all showed that the earlier
in development experiments were conducted, the higher was
the apparent permeability (expressed as brain–plasma and CSF–
plasma ratios e.g. Habgood et al., 1993). This was interpreted by
some as evidence for brain barrier “immaturity” (see Saunders,
1992, for review of earlier studies). However, extensive ultrastruc-
tural studies show that the tight junctions at brain barrier sites are
formed very early in development (Møllgård and Saunders, 1975;
Møllgård et al., 1976; Tauc et al., 1984; Ek et al., 2001, 2003, 2006).
This discrepancy between well-formed tight junctions and higher
apparent permeability in the developing brain has only recently
been resolved by the use of small lipid insoluble molecules (mainly
dextrans of different molecular size) which can be visualized at the
electron microscopical level (Ek et al., 2001, 2003, 2006). At least
in short term experiments, tight junctions in cerebral blood ves-
sels and choroid plexus epithelial cells (plexus blood vessels are
fenestrated and allow the movement of molecules between the
blood and basement membrane) are impermeable to molecules
as small as sucrose even when blood vessels ﬁrst penetrate the
brain (Figure 3). The observed drop in the concentration ratios
can be explained by the initial rapid increase in ventricular volume
(occurring as part of normal brain development), which dilutes
the entering permeability markers and a low rate of CSF secretion.
Table 1 |Tight junction protein genes enriched in mouse lateral
ventricular choroid plexus.
Gene symbol GenBank ID Fold change
TRANSMEMBRANE
(A)
Pcdh18 BC052198 6.9
Cdh5 BC054790 4.3
Cmtm3 AY241870 4.0
Cdh2 AB008811 3.4
Jam3 BC024357 3.2
Cldn11 BC021659 2.0
(B)
Igsf5 BC004806 9.6
Cldn2 BC085494 4.3
Marveld3 BC025851 4.2
Cldn12 BC024057 2.1
List of proteins known to be associated with tight junctions whose genes were
up-regulated in either the embryo (A) or the adult (B) expressed as fold change
compared to levels in other age. FromTable 4 in Liddelow et al. (2012).
Subsequent opening of the inner ventricular system to the sub-
arachnoid space and onset of CSF drainage via arachnoid villi
(Jones, 1980; Jones and Sellars, 1982; Jones and Bucknall, 1988)
with increasing CSF secretion add to further dilution of markers
entering CSF. A similar process affects brain distribution of mark-
ers because of the presence of a transient CSF–brain barrier at
the level of the neuroependymal cells lining the cerebral ventricles
(Fossan et al., 1985; Møllgård et al., 1987).
PROTEIN PERMEABILITY
The protein concentration in fetal CSF is high compared to the
adult (Dziegielewska and Saunders, 1988; Saunders et al., 1999).
Some authors have interpreted this as evidence that brain bar-
riers (both blood–CSF and blood–brain barrier) are immature
in the embryo (Adinolﬁ et al., 1976; Adinolﬁ and Haddad, 1977;
Ramey and Birge, 1979; Adinolﬁ, 1985). However, there is good
experimental evidence that this high protein concentration is a
result of transcellular transfer of plasma proteins across choroid
plexus epithelial cells (Dziegielewska et al., 1980, 1991; Habgood
et al., 1992; Knott et al., 1997; Liddelow et al., 2009, 2011a)
reinforced by the slow turnover of CSF in the developing brain
(Bass and Lundborg, 1973; Johanson and Woodbury, 1974) which
would be expected to allow proteins entering the CSF via the
choroid plexuses to accumulate to a greater extent than in the
adult (Johansson et al., 2008). These authors also provide a novel
FIGURE 3 | Light (LM) and electronmicrographs (EM) of early
developing brain blood vessels and choroid plexus, illustrating
functional effectiveness of tight junctions. (A) (LM) and (B) (EM) of
newborn opossum injected intraperitoneally (i.p.) with 3 kDa biotin dextran.
Reaction product conﬁned to vessel lumen (A) not passing through tight
junctions [(B), arrowhead]. (C) Newborn opossum choroid plexus injected
i.p. with 3 kDa biotin dextran which does not pass through tight junction
(arrowhead). (D) E15 rat, tracer injected into lateral ventricle. Choroid plexus
tight junctions (arrowhead): no passage of tracer between cells. Images:
(A,B) from Ek et al. (2006); (C,D) from Ek et al. (2003). Scale bars: (A),
25μm; (B), 200 nm; (C), 100 nm; (D), 300 nm.
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interpretation of the results by pointing out that the content of
protein in the CSF should be taken into account rather than
concentration. Concentration is a function of amounts and the
volume in which the protein is distributed. Changes in the volume
of distribution would change the concentration without altering
the actual amount (see previous section). A general and approx-
imate calculation comparing the amounts of protein in fetal and
adult CSF of several species demonstrated that in adult CSF there
is actually more protein than in the fetus in spite of CSF protein
concentration being much higher in the younger brain (Johansson
et al., 2008).
PROTEIN TRANSPORT FROM BLOOD TO CSF ACROSS THE
CHOROID PLEXUSES
Transcellular transfer of plasma proteins was ﬁrst described over
30 years ago (Dziegielewska et al., 1980). It was apparent from
the outset that the transfer exhibited a striking degree of devel-
opmentally regulated speciﬁcity. In particular it was shown that
the level of transport of albumin depended upon the species of
albumin and the animal species in which it was studied. It is
important to make the distinction between proteins made by the
choroid plexus itself, e.g., transthyretin. (Schrieber et al., 1990),
and those proteins transferred between the blood and the CSF.
However, transthyretin is also transferred from blood plasma
(Dziegielewska et al., 1980). Thus in the original experiments,
fetal sheep (E60, term is 150 days) transferred their own albu-
min and bovine albumin to the same steady state level, whereas
human and chicken albumins appeared to be discriminated to
the extent that their steady state CSF/plasma concentration ratios
were about half that of native albumin. A similar phenomenon
has been described for albumins in embryonic and neonatal rats
(Habgood et al., 1992; Johansson et al., 2006) postnatal opos-
sum (Knott et al., 1997) and in postnatal mice (unpublished). A
common characteristic of these experiments is that later in devel-
opment the species speciﬁcity for different albumins disappears
(Dziegielewska et al., 1980; Habgood et al., 1992; Knott et al.,
1997) but it could also be experimentally abolished by chemi-
cal modiﬁcation of the protein (Habgood et al., 1992; Knott et al.,
1997).
Recent application of physiological and molecular techniques
to the study of speciﬁc protein transport in the choroid plexus
revealed that the plexus epithelial cells contain a number of
receptor-/protein-binding-like molecules that have an afﬁnity for
albumin and may be the mechanism by which protein is trans-
ferred from blood to CSF (Liddelow et al., 2011b). Three genes:
Sparc, Glycophorin A (Gypa), and C (Gypc), were identiﬁed as
those whose gene products are candidates to target plasma pro-
teins to choroid plexus cells. Sparc and Gypa were identiﬁed by
immunocytochemistry in choroid plexus epithelial cells in the
embryo, subcellular distribution consistentwith transport of albu-
min from blood to CSF, as is illustrated in Figure 4. In adult plexus
this pattern of immunostaining was absent. This mechanism has
been shown to be more speciﬁc for individual plasma proteins
early in brain development and responsive to changes in concen-
trations of proteins in plasma presumably as part of a normal
homeostatic mechanism (Liddelow et al., 2009). In contrast to the
one-way (blood to CSF) transport of proteins across the choroid
plexus epithelial cells, inert dextrans are transported in both
FIGURE 4 | Proposed transepithelial pathway for albumin through
choroid plexus epithelial cells. (A)Whole choroid plexus showing single
layer of epithelial cells sitting on thick basement membrane (see also
Figure 1C). (B) Suggested routes of albumin from plasma into CSF across
the choroid plexus epithelium. GYPA/C in endothelial cells may deliver
albumin to basement membrane (1) from where it can be taken up into
plexus epithelium by GYPA/C or SPARC (2). Albumin may then travel along a
SPARC-speciﬁc pathway through tubulocisternal endoplasmic reticulum [3,
and see (C)] and Golgi (4a), or via a VAMP-mediated pathway in vacuoles,
lysosomes, or multivesicular bodies [4b, and see (C)]. On apical surface of
plexus epithelium, GYPA/C may be involved in efﬂux of protein from the cell
into CSF (5). In adult, lack of immunoreactivity in endoplasmic reticulum
and Golgi and increased expression of gene products for VAMP molecules,
suggest that majority of transport occurs via VAMP-mediated vesicular
transport (4b). (C)Transmission electron micrograph of ultracryosection
from E60 fetal sheep choroid plexus (Balslev et al., 1997b). Immunolabeled
human albumin 6 nm particles and sheep albumin 12 nm gold particles are
shown to co-localize within the tubulocisternal endoplasmic reticulum.
Abbreviations: CPEC, choroid plexus epithelial cell; CSF, cerebrospinal ﬂuid;
GYPA, glycophorin A; GYPC, glycophorin C; MVB, multivesicular body; TER,
tubulocisternal endoplasmic reticulum. Scale bar: 0.2μm in (C). Image from
Liddelow et al. (2012).
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directions (blood to CSF and CSF to blood) with twice as many
cells staining for dextrans when administered intraventricularly
than intraperitoneally (Figure 5).
The proteins transported into CSF across the choroid plexuses
have been suggested to have three functions in brain development:
(i) some of the proteins are taken up by neural cells present in the
ventricular zone that are in contact with the CSF and may have
some speciﬁc involvement in features of brain development such
as mitosis, migration, and differentiation (Stolp et al., 2011), (ii)
theymay act as carriers for growth factors,hormones and vitamins,
(iii) the high concentration of proteins in CSF early in brain devel-
opment may exert a colloid osmotic pressure within the ventricles,
thus promoting ﬂuid transfer across the choroid plexuses and con-
tributing to developmental expansion of the ventricles (essential
for normal brain growth, see Saunders et al., 1999). However, it
also needs to be considered that proteins such as albumin are
known carriers of heavy metals and drugs, thus in the presence
of such toxic molecules this normal mechanism may render the
developing brain more vulnerable to such agents (Saunders et al.,
2010; Ek et al., 2012).
UPTAKE FROM CSF INTO BRAIN
Once proteins have transferred across the choroid plexus into CSF,
some are taken up into cells in the brain. For example some neu-
roependymal cells lining the cerebral ventricles take up proteins
such as albumin and the fetal protein fetuin (Dziegielewska et al.,
2000). The initial cells that form the ﬁrst layers of the neocortex in
the embryo take up fetuin via apical dendrites that make contact
FIGURE 5 | Cellular localization of fetuin and inert biotin dextran (3 kDa)
in postnatal (P9) Monodelphis domestica. Light micrograph showing the
localization of bovine fetuin (A,B) detected with its antibodies and biotin
dextran (C,D) detected with ABC (ABC kit, Vector Laboratories), in coronal
sections of lateral ventricular choroid plexus. (A)Twenty-four hours after
intraperitoneal injection of bovine fetuin, speciﬁc epithelial cells of the plexus
(ﬁlled arrows) were found containing the protein. (B) Bovine fetuin was
injected into the lateral ventricle and left for 10min. The protein was not
detected in any cells of the plexus, or in the lumen of blood vessels in the
plexus stroma. Protein can be seen on the CSF side of the epithelial cells,
precipitated on the brush border (unﬁlled arrow). (C) Forty-ﬁve minutes after
intraperitoneal injection with BDA (3 kDa), the probe can be seen in speciﬁc
epithelial cells of the choroid plexus (ﬁlled arrow), as well as in the blood
vessel lumen (arrowhead) and precipitated in the CSF (unﬁlled arrow). (D)Ten
minutes after intraventricular injection with Fluorescein-conjugated BDA
(3 kDa), more epithelial cells take up the probe (ﬁlled arrows) following CSF
injection compared with intraperitoneal injection (C). Penetration of the
ﬂuorescent probe between epithelial cells is stopped by the presence of tight
junctions (examples highlighted by arrowheads). (E) Uptake of bovine fetuin
and BDA (3 kDa) into choroid plexus epithelial cells in P9 Monodelphis
following intraperitoneal or intracerebroventricular injection; mean±SEM,
numbers of immunostained cells. P9 Monodelphis injected with fetuin and
BDA (3 kDa) intraperitoneally or into one lateral ventricle. *Percentage of all
cells counted. n is the number of individual brains used in the study; BDA
(3 kDa), biotinylated dextran amine MW 3kDa. Scale: 50μm (A–D). From
Liddelow et al. (2009) Figure 3 andTable 7.
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with the dorsal surface of the cortex (Dziegielewska et al., 2000).
However, this uptake has been little studied and it is not clear
whether the proteins themselves are functionally important or
bound ligands such as hormones and growth factors. A recent
publication indicated that the number of plasma protein positive
cells in the ventricular zone of a fetal mouse can be increased
following an inﬂammatory response of the dam indicating that
protein uptake into the brain can be physiologically responsive to
its changing environment of Stolp et al. (2011).
INFLUX MECHANISMS ACROSS BRAIN BARRIERS IN THE
DEVELOPING BRAIN
AMINO ACID TRANSPORT
Davson (1967) summarized the available evidence on exchange
of metabolically important materials between blood and brain in
developing animals. On the one hand he accepted Bakay’s (1953)
results using 32P, which showed decreasing uptake with age, as a
qualitative indication of the state of the blood–brain barrier. On
theotherhandhepointedout that greatermetabolic incorporation
in the developing brain would also contribute to the experimental
ﬁndings. Bakay (1953) himself discussed both mechanisms and
reconciled them by suggesting that his results indicated the pres-
ence of a blood–brain barrier in the fetus (rabbit) but that it was
more permeable than in the adult. There were similar discus-
sions of the results of experiments studying the entry of amino
acids into the developing brain (Himwich et al., 1957; Roberts
et al., 1959; Purpura and Carmichael, 1960; Lajtha and Toth, 1961;
Seta et al., 1972; Baños et al., 1978) in which the entry of several
amino acids was found to be greater in younger animals than in the
adult. Kuttner et al. (1961) attempted to get round the difﬁculty
of distinguishing between cerebral endothelial cell transport and
metabolic incorporation into brain tissue by studying the uptake
of α-aminoisobutyric acid, which is transported but is metaboli-
cally inert. They reported amuch greater uptake of this amino acid
in neonatal rabbits compared to adults but interpreted this as indi-
cating “lesser effectiveness” of the blood–brain barrier for amino
acids in young animals; this interpretation was reiterated by others
(e.g., Lee, 1971). Later studies using the Oldendorf (1971) short
pass technique ormodiﬁcations of themethod, allowed separation
of entry into the brain from metabolic incorporation. This was
done by exposing the cerebral circulation of developing animals
to test amino acids and other metabolically active compounds for
only a brief period. These experiments showed that many amino
acids and other metabolically active compounds were transported
into the developing brain at much higher rates than in the adult
and was interpreted as reﬂecting the greater metabolic demand of
the developing brain rather than immaturity of the blood–brain
barrier (Braun et al., 1980; Cornford et al., 1982; Pardridge and
Mietus, 1982; Lefauconnier and Trouvé, 1983). However, some
authors have continued to suggest that this greater uptake may
reﬂect barrier immaturity (see Watson et al., 2006).
It is now clear that the transport mechanisms in the brain
barrier interfaces determine the composition of the internal envi-
ronment of developing brain and supply essential nutrients and
other molecules important for growth and differentiation of the
brain.Figure 6 summarizeswhich inward (blood–brain) transport
FIGURE 6 | Diagram of main inward transporters in cerebral
endothelial cells. Heavy metals bind to some amino acids and transferrin
receptors. Because of vulnerability of developing brain to heavy metals
this transport may contribute to fetal or newborn neurotoxicity. Compare
Table 2, which shows transporters expressed in endothelial cells from
developing brain, including those up-regulated compared to adult.
Abbreviations: ala, alanine; cys, cysteine; Fe2+, iron; Glu, glutamate; his,
histidine; MCT, monocarboxylate transporter; MeHg, methyl mercury;
met, methionine; Mn2+, manganese; Pb2+, lead; pro, proline; trp,
tryptophan; Zn2+, zinc.
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mechanisms have been shown to be functional in the fetal and
newborn brain. Much of the evidence for function of many of
these mechanisms was published some time ago and is outlined
above (see also reviews by Saunders, 1992; Saunders et al., 2010;
Saunders and Habgood, 2011; Liddelow et al., 2012).
The information that has been lacking until recently is that
on the presence and expression level of transporters in the brain
barrier interfaces in the developing brain. This is now available
from expression studies of isolated cerebral endothelial cells from
neonatal mice (Daneman et al., 2010a) and from choroid plexus
of fetal mice compared to the adult (Liddelow et al., 2012). Table 2
(from Daneman et al., 2010a) shows a summary of inﬂux trans-
porters that are up-regulated in the neonatal mouse compared to
Table 2 | Expression of transporters in endothelial cells from neonatal
mouse brain.
Gene ID Description
BBB ENRICHED INFLUXTRANSPORTERS
(A)
Slc1a1 Glutamate
Slc1a4 Alanine, serine, cysteine, threonine
Slc2a1 Glucose
Slc6a6 Taurine, β-alanine
Slc6a17 AAs, betaine, taurine, creatine
Slc7a1 Cationic AAs
Slc7a3 Cationic AAs
Slc7a5 Neutral AAs
Slc12a6 K+/Cl−
Slc16a1 Monocarboxylates
Slc16a2 Thyroid hormones
Slc16a4 Monocarboxylates
Slc19a3 Thiamine
Slc25a20 Acylcarnitines
Slc25a33 Putative
Slc30a1 Zinc
Slc31a1 Copper
Slc35f2 Putative
Slc38a3 Glutamate, Na+
Slc38a5 Neutral AAs
Slc39a10 Zinc
Slc40a1 Iron
Slc46a3 Putative
Slco1a4 Organic anions (e.g., bile acids)
Slco1c1 Thyroid hormones
Slco2b1 Prostaglandins, organic anions
(B)
Abca5
Abcb1a Multidrug resistance protein 1
Abcc4 Multidrug resistance associated protein 4
Abcg2 Breast cancer resistance protein
(A) Inﬂux transporters. Up-regulated glutamate transport probably explains neuro-
toxic effects of glutamate in immature brain, rather than barrier deﬁciency (com-
pare Figure 6). (B) Efﬂux transporters (compare Figure 7). Data from Daneman
et al. (2010a). AA, amino acid.
the adult. Table 3 shows similar data from fetal mouse choroid
plexus. It is technically difﬁcult to demonstrate how functionally
active these genes are because embryos of common experimental
animals are very small. In newborn rats and rabbits several amino
acid transporters were shown to be functional at a higher rate than
in the adult (Saunders and Habgood, 2011). Another example of
greater transport in developing brain is inward transport of phos-
phorylated lysosomal enzymes by the transporter M6P/IGF2R in
newborn mice. This transport is progressively lost with age and by
adulthood is undetectable (Urayama et al., 2008). The ﬁndings also
help to explain a number of important previous observations on
developmentally different effects of amino acids onbrain function.
For example it was reported many years ago that glutamate is toxic
to the brain if administered in the neonatal period (Olney and Ho,
Table 3 | Expression of influx transporters in embryonic mouse
choroid plexus.
Gene symbol GenBank ID Fold change
SOLUTE CARRIERS
(A)
Slc16a10 BC052877 66.8
Slc6a15 AY149280 11.4
Slc40a1 AF231120 9.6
Slc7a11 AY766236 7.1
Slc4a1 BC053429 5.5
Slc6a13 BC029637 4.6
Slc1a4 BC043483 4.4
Slc38a4 AY027919 4.2
Slc6a6 L03292 4.1
Slc4a4 AF141934 4.1
Slc7a1 M26687 4.1
Slc39a8 BC006731 3.3
(B)
Slc5a5 AF235001 13.6
Slc39a4 BC023498 9.6
Slc41a2 NM_177388 8.5
Slc24a4 AY156046 7.8
Slc28a3 BC013783 6.9
Slc24a5 AB085629 6.1
Slc9a7 BC058750 5.8
Slc6a17 AY155578 3.5
Slco1c1 AY007379 5.2
Slc4a10 AK220501 5.0
Slc39a14 AB177995 4.0
Slc35f3 BC115965 3.9
Slc13a4 BC089161 3.9
Slc37a2 AF121081 3.5
Slco1a5 AF240694 3.4
Slc39a12 BC089362 3.3
Slc46a1 BC057976 3.2
Slc25a35 BC019996 3.1
Slc22a5 AF110417 3.0
Solute carriers up-regulated in either the embryo (A) or the adult (B). FromTable
5 in Liddelow et al. (2012).
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Table 4 | Comparison of expression of influx transporters in mouse
E15 choroid plexus and published reports on transport function in the
developing brain.
Transporter Transport function
Slc16a10 IodothyroninesT3, T41
Slc6a15 Neutral amino acids2
Slc40a1* Iron3
Slc7a11 Cysteine, glutamate2
Slc4a1 Anion transporter4, (Cl−–HCO3 exchange)5
Slc6a13 GABA transporter6
Slc1a4 Glutamate, neutral amino acids7
Slc38a4 Acidic and neutral amino acids2,7
Slc6a6 Taurine2
Slc4a4 Na+ - HCO−3 cotransporter
4
Slc7a1 Acidic amino acids2
Slc39a8 Zinc transporter8
Only Slc4a4, Slc7a11, and Slc40a1 have previously been identiﬁed in choroid
plexus. Superscript numbers indicate published studies showing transport into
developing brain or CSF. *Gene product ferroportin-1 identiﬁed in choroid plexus.
1Porterﬁeld and Hendrich (1992), 2Lefauconnier and Trouvé (1983), 3Morgan and
Moos (2002), 4Damkier et al. (2010), 5Amtorp and Sørensen (1974), 6Al-Sarraf
(2002), 7Al-Sarraf et al. (1997), 8Chowanadisai et al. (2005). From Table 6 in
Liddelow et al. (2012).
1970) which some attributed to “immaturity” of the blood–brain
barrier (Viña et al., 1997). However, it can now be seen that the
barrier contribution to toxicity is much more likely to be due to
greater transport by, e.g., Slc1a4, see Table 4, which summarizes
data on expression of inﬂux transporters and published reports
on transport function in the developing brain.
AQUAPORINS
There is also good evidence for appearance of the key water
channel aquaporin-1 in very early choroid plexus epithelial cells
(Johansson et al., 2005). The development of ion gradients
between CSF and plasma in the fetal brain suggests that at least
some ionpumps are active across the blood–CSFbarrier (see Saun-
ders, 1992). Molecular expression studies in embryonic choroid
plexus conﬁrm that some ion exchange mechanisms are present
early in development (Johansson et al., 2007; Liddelow et al., 2012)
and probably also across the blood–brain barrier early in develop-
ment (Daneman et al., 2010a). Little is known of what happens if
these mechanisms become dysfunctional or develop abnormally.
EFFLUX MECHANISMS ACROSS BRAIN BARRIERS IN THE
DEVELOPING BRAIN
An important mechanism in the adult brain at both the blood–
brain and blood–CSF barriers are ATP-binding cassette (ABC)
efﬂux transporters (Hartz and Bauer, 2011). These transporters
are summarized in Figure 7. They exclude a large number of toxic
but also potentially therapeutic compounds from the brain; thus
knowledge of their presence and effectiveness in the developing
brain is essential for assessing what risk drugs and toxins may
pose. Immunohistochemical studies of P-glycoprotein in human
fetuses report its presence in cerebral endothelial cells as early as
Table 5 | Efflux (ABC) transporter expression in embryonic (A) and
adult (B) mouse choroid plexus.
Gene Other IDs Array qPCR
(A)
Abcb3 TAP2 – 16.5
Abcb6 UMAT, MTABC3 2.6 8.1
Abcg2 BCRP – 15.8
Abcg5 Sterolin1, White3 14.1 44.8
Abcg8 Sterolin2, White4 3.4 20.3
(B)
Abca2 3.5 22.4
Abca4 ABCR, RP19, RIM 9.7 12.9
Abca5 2.5 1.4
Abca7 ABCX 4.5 –
Abcb9 TAPL 2.8 1.8
Abcc1 MRP, MRP1 2.3 –
Most enriched genes during development of the mouse lateral ventricular choroid
plexus in the embryo or adult. Expression of a further 35 genes was detected at
both ages with no difference in expression levels (not shown). Array targets were
considered enriched with fold changes equal or greater than 2. From Table 7 in
Liddelow et al. (2012).
8weeks gestation (Schumacher and Møllgård, 1997). Expression
and immunohistochemical studies of brain and choroid plexuses
in embryonic and adult rats (Ek et al., 2010) have shown that
known key efﬂux transporters, multidrug resistance-associated
proteins 1 and 4, P-glycoprotein and breast cancer resistance pro-
tein (BCRP) are expressed early inbothbrain and in choroidplexus
epithelial cells and that their expression is differentially regulated
both with respect to individual efﬂux transporters and age. It is
particularly striking that BCRP is expressed at the highest level
in embryonic rat choroid plexus (20-fold compared to adult).
In the brain practically no change in expression level for BCRP
between the embryo and adult was found (Ek et al., 2010). Many
of these efﬂux mechanisms are present and functionally effec-
tive in the placenta (see Saunders et al., 2010). Data on efﬂux
transporters in embryonic and adult mouse cerebral endothe-
lial cells and choroid plexus are summarized in Tables 3B and
5. Little is known about the function of efﬂux transporters in
the human newborn brain, but it may be that because of the
loss of the protection provided by the placenta, after birth the
neonatal brain may be more vulnerable to entry of drugs and
toxins.
NEUROPATHOLOGY OF BARRIER MECHANISMS IN THE
DEVELOPING BRAIN
INFLAMMATION
The blood vessels in the developing brain are undoubtedly more
fragile than in the adult, which probably explains many of the
claims of barrier immaturity or leakiness, stemming from exper-
iments in which excessive volumes of ﬂuid have been injected
into fetuses (see Saunders, 1992 for review). A speciﬁc exam-
ple of susceptibility of cerebral blood vessels in the developing
brain is the effect of lipopolysaccharides on permeability of blood
vessels in white matter at a critical stage of brain development
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(Stolp et al., 2005a,b). These blood vessels show a leakage of
plasma proteins, demonstrated in postnatal rats and opossums at
a stage of brain development equivalent to 22–28weeks gestation
in humans (Stolp and Dziegielewska, 2009). In a clinical context
if a mother develops an infection, the fetus may be born prema-
turely and in some cases white matter damage has been observed
with the development of cerebral palsy (Dammann and Leviton,
1997; Yoon et al., 2000). Leakage of proteins from plasma into
white matter in the presence of uterine infection has been sug-
gested to be part of the etiology (Stolp and Dziegielewska, 2009).
The possible role of barrier dysfunction in the developing brain
and subsequent development of neurological/neuropsychiatric
disorders such as schizophrenia, Alzheimer’s disease and multi-
ple sclerosis has been reviewed (Stolp and Dziegielewska, 2009).
Most studies seem to have concentrated on changes in perme-
ability to large or small molecules and in properties of tight
junctions. The possibility of functionally important changes in
inﬂux (Figure 6) or efﬂux (Figure 7) mechanisms following a
pathological insult to the developing brain scarcely seems to have
been considered.
KERNICTERUS
Ek et al. (2012) have discussed some possible reasons for the per-
sisting belief amongst for, example neuropathologists and some
physiologists and pediatricians that the blood–brain barrier in the
developing brain is immature or “leaky.” A general reason was
given by Barcroft (1938) who expressed the view “There is no rea-
son why the brain of the embryo should require an environment
of very great chemical constancy. It will of course require a cer-
tain minimum of the various materials necessary for growth, but
otherwise onﬁrst principleswemight suppose that the good things
of life may exist in and may vary in the fetal blood to an extent
much greater than the maternal.” Bakay (1956) expressed a sim-
ilar view. However, teleological arguments are hardly a rigorous
way of determining the mechanism of physiological functions.
It seems likely that the proposal that the blood–brain barrier in
the fetus and newborn is immature stems in part from a view
that prevailed in the middle of the last century that kernicterus
(brain damage from excess unconjugated bilirubin in the cir-
culating blood) occurred in prematurely born infants but less
commonly in term babies and never in adult, because of imma-
turity of the blood–brain barrier (e.g., Bakay, 1953; Lee, 1971).
This appears to have been ﬁrst proposed by Spatz (1934, cited by
Davson, 1967). Once it became realized that unconjugated biliru-
bin binds to plasma albumin it was increasingly appreciated that
a key determinant of whether or not kernicterus occurred was
whether or not this binding capacity was exceeded (e.g., Bakay,
1968). However, some have continued to cite claims of immatu-
rity of the blood–brain barrier to small molecules as contributing
to kernicterus in newborn infants (Barrett et al., 2010). This over-
looks the fact that unconjugated bilirubin is lipid soluble and will
enter the brain unless bound to plasma albumin. Also greater per-
meability to small molecules in the immature brain is apparent
rather than real as it is due to slow turnover of CSF (see Apparent
Increased Permeability of Barriers in Developing Brain above).
The commonest cause of kernicterus is erythroblastosis fetalis
when excessive amounts of bilirubin are generated from break-
down of incompatible red blood cells in the case of a Rhesus
positive baby in a Rhesus negative mother. This tends to be more
frequent and more severe in prematurely born infants. However,
FIGURE 7 | Diagram of main outward transporters in cerebral endothelial
cells. Some, e.g., PGP, (P-glycoprotein) prevent entry. For others, e.g., MRP
(multidrug resistance-associated protein), ligand (drug or toxin) combines with
glutathione, glucuronic acid or sulfate in cells before efﬂux.
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there seems to be no clear-cut level of unconjugated bilirubin at
which all babies will, or will not suffer from kernicterus and it
has become increasingly clear that factors in addition to biliru-
bin binding to albumin are involved (Wennberg, 2000; Wennberg
et al., 2006). Although immaturity of the blood–brain barrier
in the sense of “leakiness” is not one of these, there are other
brain barrier mechanisms that may contribute. Thus bilirubin
is a substrate for the efﬂux transporter P-glycoprotein and pos-
sibly also other efﬂux transporters (Yokooji et al., 2010; Gazzin
et al., 2011). Although P-glycoprotein is expressed in fetal brain
endothelial cells early in gestation its levels are higher in the
adult (Schumacher and Møllgård, 1997; Virgintino et al., 2008;
Ek et al., 2010) so it is possible that the efﬂux capacity of P-
glycoprotein is exceeded in the presence of high levels of uncon-
jugated bilirubin. Other efﬂux transporters are present in fetal
cerebral endothelial cells and choroid plexus that are expressed
at higher levels in the fetus than in the adult (Ek et al., 2010,
see previous section) but it is not clear if bilirubin is also a sub-
strate for these transporters. Another factor is that as described
above there is a developmentally regulated transport of albu-
min from blood to CSF across the epithelial cells of the choroid
plexus in the fetal brain. This albumin would presumably carry
any bound unconjugated bilirubin into the CSF and thence the
brain unless removed by the efﬂux transporters in the choroid
plexuses.
CONCLUSION
Recent evidence conﬁrms that the brain develops within a well-
controlled internal environment. Tight junctions and many of the
transport mechanisms (both inward and outward) are already
present in the cellular interfaces between the blood, brain, and
CSF, very early in development. Some properties of these barrier
mechanisms and their susceptibility to disruption may lead to
brain damage and later neurological disorders. We hope that this
review will contribute to laying to rest the myth of the “leaky” or
“immature” blood–brain barrier and focus attention on the need
to understand better the level of function of barrier mechanisms
that protect the brain from exposure to drugs and toxins, so that
clinical advice will be based on the reality of evidence rather than
teleological belief.
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